Prostate cancer drug Zytiga rejected for use in Ireland

A new prostate cancer treatment has been rejected for use in Ireland.

Prostate cancer drug Zytiga rejected for use in Ireland

A new prostate cancer treatment has been rejected for use in Ireland.

Zytiga, which has been dubbed a `wonder drug', can extend the lives of late-stage prostate cancer sufferers.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited